No trials match your search ""

• A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies

  Stanford is currently accepting patients for this trial.

• A Study of Multiple Immunotherapy-Based Treatment Combinations in Hormone Receptor (HR)-Positive Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer

  Stanford is currently accepting patients for this trial.

• Molecular and Cellular Analysis of Breast Cancer

  Stanford is currently accepting patients for this trial.

• Immunohistochemical & Immunoblot Analysis of NIS (Na+/I-Symporter) in Archival & Frozen Tissue Sample

  Stanford is currently accepting patients for this trial.

• A Study of ABT-165 in Subjects With Solid Tumors

  Stanford is currently accepting patients for this trial.

• Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer

  Stanford is currently accepting patients for this trial.

• Prospective Evaluation of a Surgical Solution for Breast Cancer-Associated Lymphedema

  Stanford is currently accepting patients for this trial.

• 68-Ga-RM2 PET/MRI in Imaging Patients With Estrogen Receptor-Positive Breast Cancer

  Stanford is currently accepting patients for this trial.

• Intratumoral Tavo and Pembro in Patients With Inoperable Locally Advanced or Metastatic TNBC (KEYNOTE-890)

  Stanford is currently accepting patients for this trial.

• Study of Radiation Fractionation on Patient Outcomes After Breast REConstruction (FABREC) for Invasive Breast Carcinoma

  Stanford is currently accepting patients for this trial.

• A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer

  Stanford is currently accepting patients for this trial.

• Talazoparib For Neoadjuvant Treatment Of Germline BRCA1/2 Mutation Patients With Early Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer

  Stanford is currently accepting patients for this trial.

• G1T48, an Oral SERD, in ER-Positive, HER2-Negative Advanced Breast Cancer

  Stanford is currently accepting patients for this trial.

• Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer

  Stanford is currently accepting patients for this trial.

• Pivotal Study of Intraoperative Detection of Residual Cancer in Breast Cancer Patients

  Stanford is currently accepting patients for this trial.

• Magnetic Resonance Imaging of Breast Cancer

  Stanford is currently accepting patients for this trial.

• A Study of Atezolizumab and Paclitaxel Versus Placebo and Paclitaxel in Participants With Previously Untreated Locally Advanced or Metastatic Triple Negative Breast Cancer (TNBC)

  Stanford is currently accepting patients for this trial.

• Phase II Surgical Excision vs Neoadjuvant Radiotherapy+Delayed Surgical Excision of Ductal Carcinoma

  Stanford is currently accepting patients for this trial.

• Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples

  Stanford is currently accepting patients for this trial.

• Transversus Abdominis Plane Block in Microsurgical Breast Recon w/Abdominal Free Flap in Breast CA

  Stanford is currently accepting patients for this trial.

• Previous
• 1
• 2
• Next

No trials match your search ""

No trials match your search ""

No trials match your search ""

No trials match your search ""

No trials match your search ""

• International Lymphatic Disease and Lymphedema Registry

  Stanford is currently accepting patients for this trial.

• Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumors That Have Been Removed By Surgery

  Stanford is currently accepting patients for this trial.

• A Trial of E7777 in Persistent and Recurrent Cutaneous T-Cell Lymphoma

  Stanford is currently accepting patients for this trial.

• Assessment of Patient Experience During Treatment for Cancer

  Stanford is currently accepting patients for this trial.

• Pembrolizumab and Interferon Gamma-1b in Treating Patients With Stage IB-IVB Relapsed or Refractory Mycosis Fungoides and Sezary Syndrome

  Stanford is currently accepting patients for this trial.

• PD-1 in Patients With Advanced Basal Cell Carcinoma Who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy, or Were Intolerant of Prior Hedgehog Pathway Inhibitor Therapy

  Stanford is currently accepting patients for this trial.

• A Study of IMO-2125 in Combination With Ipilimumab Versus Ipilimumab Alone in Subjects With Anti-PD-1 Refractory Melanoma (ILLUMINATE-301)

  Stanford is currently accepting patients for this trial.

• Pembrolizumab Versus Placebo Following Surgery and Radiation in Participants With Locally Advanced Cutaneous Squamous Cell Carcinoma (MK-3475-630/KEYNOTE-630)

  Stanford is currently accepting patients for this trial.

• Pre-Operative Cemiplimab Administered Intralesionally for Patients With Recurrent Cutaneous Squamous Cell Carcinoma

  Stanford is currently accepting patients for this trial.

• A Study of INCMGA00012 in Metastatic Merkel Cell Carcinoma (POD1UM-201)

  Stanford is currently accepting patients for this trial.

• Palliative RT & Anti-PD-1/PD-L1 Checkpoint Blockade in Metastatic Merkel Cell Carcinoma

  Stanford is currently accepting patients for this trial.

• Topical Remetinostat Gel as Neoadjuvant Therapy in Patients With Squamous Cell Carcinoma (SCC)

  Stanford is currently accepting patients for this trial.

• CemiplimAb Survivorship Epidemiology

  Stanford is currently accepting patients for this trial.

• Study of REGN2810 in Patients With Advanced Cutaneous Squamous Cell Carcinoma

  Stanford is currently accepting patients for this trial.

• Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors

  Stanford is currently accepting patients for this trial.

• Olaparib and Temozolomide in Treating Patients With Advanced, Metastatic, or Unresectable Uterine Leiomyosarcoma

  Stanford is currently accepting patients for this trial.

• A Phase III Trial of Anlotinib in Metastatic or Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma and Synovial Sarcoma

  Stanford is currently accepting patients for this trial.

• A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies

  Stanford is currently accepting patients for this trial.

• ADI-PEG 20 in Combination With Gemcitabine and Docetaxel for the Treatment of Soft Tissue Sarcoma

  Stanford is currently accepting patients for this trial.

• Selinexor in Advanced Liposarcoma

  Stanford is currently accepting patients for this trial.

• Trametinib in Treating Patients With Epithelioid Hemangioendothelioma That Is Metastatic, Locally Advanced, or Cannot Be Removed by Surgery

  Stanford is currently accepting patients for this trial.

• Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma

  Stanford is currently accepting patients for this trial.

• Spearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma

  Stanford is currently accepting patients for this trial.

• Incisional Negative Pressure Wound Therapy for Preoperatively Irradiated Lower Extremity Soft Tissue Sarcoma Wounds

  Stanford is currently accepting patients for this trial.

No trials match your search ""